NYMBRIEL Trademark

Trademark Overview


On Thursday, November 19, 2015, a trademark application was filed for NYMBRIEL with the United States Patent and Trademark Office. The USPTO has given the NYMBRIEL trademark a serial number of 86825490. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 5, 2024. This trademark is owned by Glaxo Group Limited. The NYMBRIEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Vaccines
nymbriel

General Information


Serial Number86825490
Word MarkNYMBRIEL
Filing DateThursday, November 19, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 5, 2024
Registration Number5225855
Registration DateTuesday, June 20, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Vaccines
Translation of Words in MarkThe wording "NYMBRIEL" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, January 5, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 20, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 20, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, April 27, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, May 15, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 27, 2017TEAS DELETE 1(B) BASIS RECEIVED
Saturday, October 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2016SOU EXTENSION 1 GRANTED
Thursday, October 13, 2016SOU EXTENSION 1 FILED
Thursday, October 13, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 10, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 3, 2016ASSIGNED TO LIE
Friday, January 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 8, 2016EXAMINER'S AMENDMENT ENTERED
Friday, January 8, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 8, 2016EXAMINERS AMENDMENT E-MAILED
Friday, January 8, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, January 8, 2016ASSIGNED TO EXAMINER
Tuesday, November 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 23, 2015NEW APPLICATION ENTERED